Literature DB >> 6224012

Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea.

A Tyler, P S Harper.   

Abstract

Ninety-two patients suffering from Huntington's chorea (HC) and their spouses, and 91 subjects with an affected parent and their spouses, living in three counties of industrial South Wales, have been studied regarding their knowledge of their inheritance of the disorder. Particular attention was paid to its influence on their attitudes towards child-bearing, telling their children of the risks, and predictive tests. Only 12% of the patients were known to have received professional advice before completing their families, in contrast to 68% of the sample at risk. It is estimated that 82% of the patients and 60% of the subjects at risk had, or might have, restricted their family size had they known in time. The majority found genetic counselling helpful, but did not necessarily wish to alter their child-bearing plans in consequence. It was clear that information provided by the family alone was usually inadequate and that this applied to the present generation at risk as well as to previous generations. It was concluded that the burden of telling children the risks is too great for most parents and that professional help is needed. The long term impact of genetic counselling on the incidence of the disease is impossible to assess without continued monitoring, but preliminary results are encouraging. Attitudes towards a predictive test reflected much conflict: although 56% overall wished to take one, only 40% of those who were parents wished to know if they were at risk of passing the gene on to their children. Few subjects reported severe social stress on learning of their genetic risks, but about one in four reported experiencing significant anxiety.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1983        PMID: 6224012      PMCID: PMC1049042          DOI: 10.1136/jmg.20.3.179

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Attitudes of families to some aspects of Huntington's chorea.

Authors:  J Barette; C D Marsden
Journal:  Psychol Med       Date:  1979-05       Impact factor: 7.723

2.  Social aspects of Huntington's Chorea.

Authors:  M B Hans; T H Gilmore
Journal:  Br J Psychiatry       Date:  1968-01       Impact factor: 9.319

3.  Genetic counseling: a consumers' view.

Authors:  C O Leonard; G A Chase; B Childs
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

4.  Decline in the predicted incidence of Huntington's chorea associated with systematic genetic counselling and family support.

Authors:  P S Harper; A Tyler; S Smith; P Jones; R G Newcombe; V McBroom
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

5.  Complexities of parental understanding of phenylketonuria.

Authors:  M S Sibinga; C J Friedman
Journal:  Pediatrics       Date:  1971-08       Impact factor: 7.124

6.  Counselling and Huntington's chorea.

Authors:  C O Carter; K Evans
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

7.  Huntington's Chorea in South Wales. A genetic and epidemiological study.

Authors:  D A Walker; P S Harper; C E Wells; A Tyler; K Davies; R G Newcombe
Journal:  Clin Genet       Date:  1981-04       Impact factor: 4.438

8.  Attitudes of patients and their relatives to Huntington's disease.

Authors:  R Stern; R Eldridge
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

9.  Huntington's chorea. The basis for long-term prevention.

Authors:  P S Harper; D A Walker; A Tyler; R G Newcombe; K Davies
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

10.  Objective knowledge about Huntington's disease and attitudes towards predictive tests of persons at risk.

Authors:  B Teltscher; S Polgar
Journal:  J Med Genet       Date:  1981-02       Impact factor: 6.318

View more
  14 in total

1.  The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.

Authors:  Luísa Rolim; José A Zagalo-Cardoso; Constança Paúl; Jorge Sequeiros; Manuela Fleming
Journal:  J Genet Couns       Date:  2006-09-27       Impact factor: 2.537

2.  Genetic testing preferences in families containing multiple individuals with epilepsy.

Authors:  Janice O Okeke; Virginia E Tangel; Shawn T Sorge; Dale C Hesdorffer; Melodie R Winawer; Jeff Goldsmith; Jo C Phelan; Wendy K Chung; Sara Shostak; Ruth Ottman
Journal:  Epilepsia       Date:  2014-09-29       Impact factor: 5.864

Review 3.  The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature.

Authors:  S Crozier; N Robertson; M Dale
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

4.  Ethics of predictive testing for Huntington's chorea: the need for more information.

Authors:  D I Craufurd; R Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

5.  Nonparticipation in Huntington's Disease Predictive Testing: Reasons for Caution in Interpreting Findings.

Authors:  J Binedell; J R Soldan
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

6.  Ethical dilemmas in clinical genetics.

Authors:  I D Young
Journal:  J Med Ethics       Date:  1984-06       Impact factor: 2.903

7.  A genetic marker for Huntington's chorea.

Authors:  P S Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

8.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

Review 9.  Huntington's disease and the ethics of genetic prediction.

Authors:  G Terrenoire
Journal:  J Med Ethics       Date:  1992-06       Impact factor: 2.903

10.  Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.

Authors:  G Evers-Kiebooms; J J Cassiman; H van den Berghe
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.